Table 3 Events (cardiac death or heart transplantation) according to baseline characteristics (A) and blood pressure profile (B)
From: Prognostic value of systolic short-term blood pressure variability in systolic heart failure
| A. | |||
| Baseline characteristics | Event (n = 70) | No event (n = 218) | p |
| Age, years | 62 ± 12 | 59 ± 12 | 0.1 |
| Male, n (%) | 60 (86) | 167 (77) | 0.1 |
| BMI | 25.2 ± 3.6 | 26.2 ± 5.8 | 0.03 |
| NYHA I &II, n (%) | 18 (26) | 135 (62) | <0.001 |
| NYHA III&IV, n (%) | 52 (74) | 83 (38) | |
| LVEF, % | 27 ± 10 | 29 ± 9 | 0.2 |
| Congestive HF, n (%) | 39 (55) | 83 (38) | <0.05 |
| Diabetes, n (%) | 19 (27) | 42 (19) | 0.16 |
| Hypertension, n (%) | 22 (31) | 103 (47) | 0.02 |
| Ischemic, n (%) | 34 (49) | 97 (44) | 0.5 |
| Cockcroft, ml/min | 64 ± 24 | 72 ± 28 | <0.05 |
| Heart rate, bpm | 79 ± 15 | 79 ± 18 | 0.8 |
| ACE inhibitor, n (%) | 54 (77) | 187 (86) | 0.09 |
| ARA2, n (%) | 7 (10) | 12 (6) | 0.19 |
| Spironolactone, n (%) | 34 (49) | 106 (49) | 0.99 |
| B-blockers, n (%) | 38 (54) | 141 (65) | 0.12 |
| Ca-channel blockers, n (%) | 1 (1) | 12 (6) | 0.15 |
| Nitride, n (%) | 12 (17) | 43 (20) | 0.6 |
| Diuretics, n (%) | 66 (94) | 182 (83) | 0.02 |
| B. | |||
| Blood pressure profile | Event (n = 70) | No event (n = 218) | p |
| SBP 24-h, mmHg | 107 ± 15 | 111 ± 15 | 0.05 |
| SBP daytime, mmHg | 108 ± 16 | 113 ± 15 | 0.03 |
| SBP nighttime, mmHg | 104 ± 15 | 108 ± 17 | 0.13 |
| DBP 24-h, mmHg | 66 ± 9 | 69 ± 9 | 0.06 |
| DBP daytime, mmHg | 68 ± 9 | 71 ± 10 | <0.05 |
| DBP nighttime, mmHg | 64 ± 10 | 66 ± 11 | 0.24 |
| DIP, mmHg | 3.4 ± 5 | 4.5 ± 7 | 0.23 |
| PP daytime, mmHg | 40 ± 11 | 42 ± 10 | 0.13 |
| PP nighttime, mmHg | 40 ± 11 | 42 ± 11 | 0.22 |
| BPV daytime, mmHg | 22 ± 6 | 24 ± 9 | <0.05 |
| BPV nighttime, mmHg | 17 ± 6 | 18 ± 8 | 0.4 |